The importance of effector cells in the control of HIV infection is further supported by recent observations by Picker and colleagues who found that a rhesus-CMV-based SIV vaccine vector could stimulate protective effector SIV-specific CD8+ T-cells [52]. The gene discussed is CD8A; the disease is HIV infectious disease.